Advertisement

Topics

RMEI Medical Education (RMEI) and Crohn's & Colitis Foundation Company Profile

07:09 EDT 24th March 2019 | BioPortfolio

The Crohn's & Colitis Foundation (the Foundation) is the largest non-profit, voluntary, health organization dedicated to finding cures for inflammatory bowel diseases (IBD). The Foundation’s mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults who suffer from these diseases. The Foundation works to fulfill its mission by funding research; providing educational resources for patients and their families, medical professionals, and the public; and furnishing supportive services for those afflicted with IBD. For more information visit www.crohnscolitisfoundation.org, call 888-694-8872, or email info@crohnscolitisfoundation.org.


News Articles [1884 Associated News Articles listed on BioPortfolio]

Reporters invited to attend leading IBD meeting: Crohn's & Colitis Congress®

(American Gastroenterological Association) The Crohn's & Colitis Congress, the premier conference for inflammatory bowel diseases (IBD) health care providers and researchers, invites media to register...

Predictimmune and the Crohn’s & Colitis Foundation Announce a Joint Study to Validate and Prove Efficacy of First Prognostic Test for IBD in the US Market

The jointly-sponsored study is expected to advance progress towards personalised medicine for IBD patients in the US PredictImmune, developers of pioneering prognostic tools f...

Innovation Pharmaceuticals Presenting Brilacidin for Inflammatory Bowel Disease at “IBD Innovate 2018” Conference Hosted by the Crohn’s & Colitis Foundation

BEVERLY, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to announce that the Company is...

Innovation Pharmaceuticals Brilacidin as a Novel Inhibitor of Phosphodiesterase 4 (PDE4) Supports its Potential to Treat Autoimmune and Inflammatory Diseases; Company Invited to Present at Upcoming Crohn’s & Colitis Foundation Conference

BEVERLY, Mass., Oct. 12, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to provide this update on Bril...

Medical News Today: What to expect from Crohn's infusions

Crohn's infusions are medications called biologics that can help reduce Crohn's symptoms. Learn about the types of Crohn's infusions, the side effects, and what to expect.

Medical News Today: What are the stages of Crohn's disease?

Crohn's disease causes chronic inflammation in the digestive tract. Although Crohn's disease tends to get worse over time, symptoms can vary considerably and may sometimes disappear for weeks or even ...

Families Caring for Individuals with Crohn's Disease and Ulcerative Colitis to be Focus of Caregiving Study

The National Alliance for Caregiving, Crohn’s and Colitis Foundation, and ImproveCareNow Partner to Understand the Impact of Inflammatory Bowel Diseases (IBD) on Caregivers WASHINGTON (PRWEB) Septem...

Medical News Today: What are the facts of Crohn's disease?

Crohn’s disease is a chronic condition that causes inflammation along the digestive tract. Here, we discuss Crohn’s disease facts, including causes, risk factors, prevalence, treatment options, an...

Drugs and Medications [122 Associated Drugs and Medications listed on BioPortfolio]

Humira [a-s medication solutions]

These highlights do not include all the information needed to use HUMIRA safely and effectively. See full prescribing information for HUMIRA. HUMIRA (adalimumab) injection, for subcutaneous useInitial...

Humira [abbvie inc.]

These highlights do not include all the information needed to use HUMIRA safely and effectively. See full prescribing information for HUMIRA. HUMIRA (adalimumab) injection, for subcutaneous useInitial...

Entyvio [takeda pharmaceuticals america, inc.]

These highlights do not include all the information needed to use ENTYVIO safely and effectively. See full prescribing information for ENTYVIO.ENTYVIO (vedolizumab) for injection, for intravenous use...

No7 protect and perfect foundation sunscreen broad spectrum spf 15 calico [boots retail usa inc]

NA

Amlodipine besylate [kaiser foundation hospitals]

These highlights do not include all the information needed to use amlodipine besylate tablets USP safely and effectively. See full prescribing information for amlodipine besylate tablets USP. Amlodipi...

PubMed Articles [3868 Associated PubMed Articles listed on BioPortfolio]

Diffuse colitis cystica profunda in Crohn's disease: A potential diagnostic pitfall.

Significant medical and surgical morbidity in perianal Crohn's disease: Results from a territory-wide study.

Presence of perianal fistulas in Crohn's disease (CD) denotes increased disease aggressiveness. We studied epidemiology and clinical outcomes of perianal CD (PCD) using Hong Kong territory-wide IBD Re...

Difference in Pathomechanism Between Crohn's Disease and Ulcerative Colitis Revealed by Colon Transcriptome.

We aim to identify the differences in colonic mucosal transcriptome between Crohn's disease (CD) and ulcerative colitis (UC) for a better understanding of the molecular pathology.

Gene and Mirna Regulatory Networks During Different Stages of Crohn's Disease.

Early treatment of Crohn's disease (CD) is required to optimize patient outcomes. To this end, we need to gain a better understanding of the molecular changes at the onset of CD.

Musculoskeletal Radiology Teaching at a UK Medical School: Do We Need to Improve?

The United Kingdom is currently facing crisis due to a shortage of radiology consultants despite ever-increasing demand for medical imaging. The specifics of how best to teach radiology has generated ...

Clinical Trials [5332 Associated Clinical Trials listed on BioPortfolio]

Endoscopic Ultrasound Determines Disease Activity in Crohn's Disease And Ulcerative Colitis

Although Crohn's disease and ulcerative colitis are the main subtypes of inflammatory bowel disease, they differ substantially in disease behavior, prognosis, and treatment paradigm. Howev...

Risk Factors for Microscopic Colitis

Microscopic colitis is a common cause of watery diarrhea, particularly in the elderly. Although the incidence is comparable to ulcerative colitis and Crohn's disease, the etiology is unkno...

A Phase 2, Randomized, Double-Blind, Dose-Ranging Study With Vedolizumab IV in Pediatric Participants With Ulcerative Colitis or Crohn's Disease

The purpose of this study is to evaluate vedolizumab pharmacokinetics (PK), safety and tolerability in pediatric participants with moderately to severely active ulcerative colitis or Crohn...

Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)

To collect information on the safety and effectiveness of Infliximab BS for Intravenous Drip Infusion 100 mg "Pfizer" against Crohn's disease or ulcerative colitis under actual status of u...

Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease

The purpose of this study is to monitor ongoing safety in subjects with ulcerative colitis (UC) and Crohn's disease (CD) and to provide access to vedolizumab for qualifying subjects who, i...

Companies [3809 Associated Companies listed on BioPortfolio]

RMEI Medical Education (RMEI) and Crohn's & Colitis Foundation

The Crohn's & Colitis Foundation (the Foundation) is the largest non-profit, voluntary, health organization dedicated to finding cures for inflammatory bowel diseases (IBD). The F...

RMEI Medical Education (RMEI)

Founded in 1990, RMEI Medical Education (RMEI) is one of the longest operating medical education companies in the U.S. With an emphasis on sophisticated learner analytics for prog...

Crohn's & Colitis Foundation of America

The Crohn's & Colitis Foundation of America is the largest non-profit, volunteer-driven organization dedicated to finding a cure for Crohn's disease and ulcerative colitis, and it ranks third among le...

RMEI

Crohns & Colitis Foundation of America

Crohn's disease, a chronic inflammatory disease of the gastrointestinal tract, affects approximately 500,000 Americans, including approximately 100,000 pediatric patients. The cause of Crohn's diseas...

More Information about "RMEI Medical Education (RMEI) and Crohn's & Colitis Foundation" on BioPortfolio

We have published hundreds of RMEI Medical Education (RMEI) and Crohn's & Colitis Foundation news stories on BioPortfolio along with dozens of RMEI Medical Education (RMEI) and Crohn's & Colitis Foundation Clinical Trials and PubMed Articles about RMEI Medical Education (RMEI) and Crohn's & Colitis Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of RMEI Medical Education (RMEI) and Crohn's & Colitis Foundation Companies in our database. You can also find out about relevant RMEI Medical Education (RMEI) and Crohn's & Colitis Foundation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Crohn's Disease (CD)
Crohn’s disease (CD) is a long-term condition that causes inflammation of the lining of the digestive system.  Inflammation can affect any part of the digestive system, from the mouth to the back passage, but most commonly occurs in the last s...


Corporate Database Quicklinks



Searches Linking to this Company Record